Almirall has completed the decentralised regulatory procedure in Europe for efinaconazole to treat onychomycosis.

Almirall has completed the decentralized EU regulatory procedure for efinaconazole (Jublia) for onychomycosis. The final step ...

Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful ...

用于生产增值燃料和原料的电化学CO 2 还原反应通常依赖于金属基催化剂。有机分子催化剂比金属催化剂更具可调谐性，但仍无法在工业相关电流密度下长期运行将CO 2 催化成碳氢化合物，且催化机理仍不清楚。